BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
80.96
-0.42 (-0.52%)
At close: Nov 20, 2026, 4:00 PM EST
81.12
+0.16 (0.20%)
After-hours: Nov 20, 2026, 7:42 PM EST
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $20.07 billion as of November 20, 2026. It is the 1,134th most valuable company in the world and the 463rd biggest in the United States. Its market cap has decreased by 17.70% in one year.
Market Cap
20.07B
Enterprise Value
4.93B
1-Year Change
-17.70%
Global Rank
Country Rank
#463 United States
Category
ChartMarket Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $20.07B, an increase of 570.20%. That is a compound annual growth rate of 30.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 20.07B | -12.32% |
| Dec 31, 2025 | 22.89B | -16.21% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 (IPO) | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Revolution Medicines | 34.87B |
| Genmab | 32.26B |
| Insmed | 31.01B |
| Roivant Sciences | 28.01B |
| Incyte | 23.36B |
| Alnylam Pharmaceuticals | 19.26B |
| Ascendis Pharma | 16.58B |
| Exelixis | 15.77B |